Format

Send to

Choose Destination
Science. 2001 Mar 2;291(5509):1790-2.

Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli.

Author information

1
Department of Chemical Engineering, Stanford University, Stanford, CA 94305-5025, USA.

Abstract

The macrocyclic core of the antibiotic erythromycin, 6-deoxyerythronolide B (6dEB), is a complex natural product synthesized by the soil bacterium Saccharopolyspora erythraea through the action of a multifunctional polyketide synthase (PKS). The engineering potential of modular PKSs is hampered by the limited capabilities for molecular biological manipulation of organisms (principally actinomycetes) in which complex polyketides have thus far been produced. To address this problem, a derivative of Escherichia coli has been genetically engineered. The resulting cellular catalyst converts exogenous propionate into 6dEB with a specific productivity that compares well with a high-producing mutant of S. erythraea that has been incrementally enhanced over decades for the industrial production of erythromycin.

PMID:
11230695
DOI:
10.1126/science.1058092
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center